Insider Cluster (2 insiders) ·Filed Jul 9, 2026

GKOS

GLAUKOS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The insider selling is routine and quantitatively trivial relative to market cap. No bearish signal. Monitor upcoming earnings or product announcements for any fundamental changes, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
GKOS ▲ +10.27% at T+20d
NEUTRAL call ✓ call won +10.27% · α vs SPY +8.02% · entry $155.07 → $170.99
Next anchor: T+60d due yesterday
Latest observation: T+57 -15.01% FF3 residual α
Entry anchored
Jul 8, 03:59 PM ET
via exchange tick
T+1d
-1.52%
call -1.52% · α -1.95%
$152.72
settled 3mo ago
T+5d
+0.21%
call +0.21% · α +0.34%
$155.39
settled 3mo ago
T+20d
+10.27%
call +10.27% · α +8.02%
$170.99
settled 8w ago
T+60d
—
call — · α —
—
due yesterday

Price Chart

Loading chart...

Executive Summary

Two Glaukos insiders (CFO and Chief Development Officer) sold a combined $1.6M in shares over a 7-day window. The CFO's sale followed option exercises at $38.68, a typical same-day exercise-and-sell pattern. At $8.8B market cap, the total sales represent only ~0.018% of market cap — well below the 0.1% threshold for materiality. This is routine insider selling with no bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.6M
Insiders
2

Key Facts

  • CFO Thurman Alex R. sold 10,000 shares at $150 on 2026-07-06 after exercising options at $38.68 (same-day exercise-and-sell).
  • Chief Development Officer Navratil Tomas sold 716 shares at $139.06 on 2026-07-01.
  • Total insider sales of $1.6M represent only ~0.018% of Glaukos' $8.8B market cap.
  • Both sales are open-market sells; no insider purchases were reported in the cluster.

Financial Impact

Total insider sales of $1.6M, immaterial relative to $8.8B market cap.

dilution

Risk Factors

  • Insider selling could increase if the stock continues to appreciate, but current levels are not alarming.
  • Any future cluster with >0.5% of market cap sold would be more significant.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GKOS-1783559630432
8 reports for GKOS
Performance horizon
Filters
Rows
Reports for GKOS — sortable, filterable
TypeNow
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$184.53 $171.09▼ −7.28%▼ −5.29%$165.29 (−10.43%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$186.63 $170.38▼ −8.71%▼ −6.81%$165.29 (−11.43%)
Aug 3, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$170.87 $179.56▲ +5.09%▲ +3.85%$165.29 (−3.26%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$155.07 $170.99▲ +10.27%▲ +8.02%$165.29 (+6.59%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$135.85 $103.12▼ −24.09%▼ −29.74%$165.29 (+21.67%)
May 1, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$140.22 $103.12▼ −26.46%▼ −31.74%$165.29 (+17.88%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.94 $120.52▲ +21.81%▲ +18.03%$165.29 (+67.06%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.94 $120.52▲ +21.81%▲ +18.03%$165.29 (+67.06%)
Showing 8 of 8

US Market Status

Market Open — Closes in 3h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 9, 2026